HIMS

Hims Hers Health Inc

HIMS.US hims.com
28.67
+1.16 (+4.22%)
USD · NYSE
52-week range
13.74
65.30
Trading at 29% of the 52-week range
Market Cap
6.42B
P/E Ratio
0.00
Forward P/E
71.43
Book Value
1.39
Div. Yield
N/A
% Institutions
71.47%
% Insiders
4.97%

1 Year

-46.9%

3 Year

+325.9%

10 Year

+180.7%
Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Company Information

Company Name
Hims Hers Health Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US4330001060
CIK: 0001773751
CUSIP: 433000106
Currency: USD
Full Time Employees: 2,442
Phone: 415 851 0195
Website: hims.com
Fiscal Year End: December
IPO Date: Sep 13, 2019
Description:

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Address:

2269 Chestnut Street, San Francisco, CA, United States, 94123

People

Directors & Officers

Name Title Year Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1988
Mr. Oluyemi Okupe Chief Financial Officer 1986
Mr. Mike Chi Chief Operating Officer 1980
Mr. Mohamed ElShenawy Chief Technology Officer 1975
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary 1978
Dr. Patrick Carroll M.D. Global Chief Medical Officer 1958
Ms. Deborah M. Autor J.D. Chief Policy Officer & Director 1967
Ms. Irene A. Becklund Chief Accounting Officer 1984
Mr. William James Newby Senior Director of Investor Relations NA
Ms. Kathryn H. Beiser B.A., M.S. Chief Communications Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 20, 2026 Soleil Boughton N/A Sale 9.46K $30.00 $283.89K
Apr 20, 2026 Oluyemi Okupe N/A Sale 19.65K $29.96 $588.56K
Apr 17, 2026 Oluyemi Okupe N/A Sale 18.01K $27.83 $501.08K
Apr 16, 2026 Oluyemi Okupe N/A Sale 36.92K $25.90 $956.28K
Apr 06, 2026 Oluyemi Okupe N/A Sale 3.98K $19.98 $79.42K
Mar 20, 2026 Oluyemi Okupe N/A Sale 9.22K $23.77 $219.09K
Mar 17, 2026 Irene Becklund N/A Sale 5.53K $24.69 $136.51K
Mar 17, 2026 Michael Chi N/A Sale 97.29K $24.69 $2.40M
Mar 17, 2026 Soleil Boughton N/A Sale 4.81K $24.69 $118.81K
Feb 03, 2026 Tony Wied N/A Purchase N/A $25.53 N/A
Jan 20, 2026 Oluyemi Okupe N/A Sale 9.07K $30.34 $275.09K
Jan 05, 2026 Oluyemi Okupe N/A Sale 9.07K $33.79 $306.48K
Dec 22, 2025 Oluyemi Okupe N/A Sale 23.09K $35.72 $824.77K
Dec 17, 2025 Deborah M Autor N/A Sale 7.05K $36.71 $258.95K
Dec 17, 2025 Irene Becklund N/A Sale 8.41K $36.71 $308.77K
Dec 17, 2025 Michael Chi N/A Sale 13.75K $36.71 $504.76K
Dec 17, 2025 Patrick Harrison Carroll N/A Sale 10.02K $36.71 $367.87K
Dec 09, 2025 Garcia Andrea G Perez N/A Sale 2.50K $39.17 $97.93K
Nov 17, 2025 Oluyemi Okupe N/A Sale 23.19K $36.81 $853.51K
Nov 17, 2025 Oluyemi Okupe N/A Sale 23.19K $36.81 $853.51K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 26.34M Mar 31, 2026 11.29% $0.01 -0.89%
Vanguard Portfolio Management, LLC 10.18M Mar 31, 2026 4.36% $0.01 0.00%
Vanguard Capital Management, LLC 9.34M Mar 31, 2026 4.00% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 8.89M Mar 31, 2026 3.81% $0.01 126.23%
State Street Corp 7.46M Mar 31, 2026 3.20% $0.01 2.11%
Defiance ETFs, LLC 7.42M Mar 31, 2026 3.18% $2.21 0.00%
JPMorgan Chase & Co 5.24M Mar 31, 2026 2.25% $0.01 -72.18%
Geode Capital Management, LLC 5.20M Mar 31, 2026 2.23% $0.01 -5.64%
Bank of America Corp 4.36M Mar 31, 2026 1.87% $0.01 194.41%
UBS Group AG 4.15M Mar 31, 2026 1.78% $0.01 -8.74%
The Goldman Sachs Group Inc 2.45M Mar 31, 2026 1.05% $0.01 -76.28%
Northern Trust Corp 2.44M Mar 31, 2026 1.04% $0.01 2.87%
Charles Schwab Investment Management Inc 2.36M Mar 31, 2026 1.01% $0.01 -1.64%
State Treasurer State Of Michigan 2.35M Jun 30, 2026 1.01% $0.36 0.33%
Renaissance Technologies Corp 2.12M Mar 31, 2026 0.91% $0.07 -56.04%
Principal Financial Group Inc 1.67M Jun 30, 2026 0.71% $0.03 30.01%
Susquehanna International Group, LLP 1.63M Mar 31, 2026 0.70% $0.00 0.18%
Vanguard Fiduciary Trust Co 1.45M Mar 31, 2026 0.62% $0.01 0.00%
Fuller & Thaler Asset Management Inc 1.42M Mar 31, 2026 0.61% $0.10 0.00%
T. Rowe Price Associates, Inc. 1.42M Mar 31, 2026 0.61% $0.00 95.10%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 7.42M 3.18% ▲ 0.04% Aug 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 6.74M 2.89% ▲ 0.30% Jul 31, 2026
3 iShares Russell 2000 ETF 5.50M 2.36% ▼ 0.57% Aug 31, 2026
4 Vanguard Small Cap Index 4.87M 2.09% ▲ 0.25% Jul 31, 2026
5 Vanguard MStar Small Cap Growth Indx Inv 2.82M 1.21% ▲ 0.44% Jul 31, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 2.44M 1.05% ▲ 0.26% Jul 31, 2026
7 Fidelity Small Cap Index 2.34M 1.00% ▲ 14.73% Jun 30, 2026
8 iShares Russell 2000 Growth ETF 2.03M 0.87% ▲ 0.26% Aug 31, 2026
9 JPMorgan Large Cap Growth I 1.98M 0.85% ▲ 0.00% Jul 31, 2026
10 State Street® SPDR® S&P MIDCAP 400® ETF 1.57M 0.67% ▼ 3.88% Jul 31, 2026

Financial Highlights

Market Cap: $6.42B
EBITDA: $-10.18M
PEG Ratio: $2.51
Book Value: $1.39
Earnings/Share: $-0.64
Profit Margin: -5.51%
Operating Margin: -12.75%
ROA (TTM): -2.21%
ROE (TTM): -32.03%
Revenue (TTM): $2.58B
Revenue/Share (TTM): $11.29
Earnings Growth (YOY): -17.40%
Revenue Growth (YOY): 38.20%

Valuation Metrics

Enterprise Value: $7.12B
Trailing P/E: 0.00
Forward P/E: 71.43

Shares Statistics

Shares Outstanding: 224.94M
Shares Float: 213.69M
% Insiders: 4.97%
% Institutions: 71.47%
Short % Float: 28.31%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2.35B
Cost of Goods Sold
adjust
$-614.26M
Gross Profit
subtotal
$1.73B
SG&A
adjust
$-272.72M
R&D
adjust
$-149.30M
Other Operating Expense
adjust
$-1.21B
Operating Income
subtotal
$105.61M
Other / Non-Operating Items
adjust
$22.75M
Net Income
subtotal
$128.37M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HIMS.US!